PTC Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.

About PTCT

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ. 

CEO
Matthew B. Klein
CEOMatthew B. Klein
Employees
991
Employees991
Headquarters
Warren, New Jersey
HeadquartersWarren, New Jersey
Founded
1998
Founded1998
Employees
991
Employees991

PTCT Key Statistics

Market cap
5.83B
Market cap5.83B
Price-Earnings ratio
-117.58
Price-Earnings ratio-117.58
Dividend yield
Dividend yield
Average volume
853.67K
Average volume853.67K
High today
$71.36
High today$71.36
Low today
$69.79
Low today$69.79
Open price
$70.54
Open price$70.54
Volume
643.64K
Volume643.64K
52 Week high
$90.87
52 Week high$90.87
52 Week low
$48.28
52 Week low$48.28

Stock Snapshot

PTC Therapeutics(PTCT) stock is priced at $69.82, giving the company a market capitalization of 5.83B. It carries a P/E multiple of -117.58.

On 2026-08-22, PTC Therapeutics(PTCT) stock traded between a low of $69.79 and a high of $71.36. Shares are currently priced at $69.82, which is +0.0% above the low and -2.2% below the high.

The PTC Therapeutics(PTCT)'s current trading volume is 643.64K, compared to an average daily volume of 853.67K.

During the past year, PTC Therapeutics(PTCT) stock moved between $48.28 at its lowest and $90.87 at its peak.

During the past year, PTC Therapeutics(PTCT) stock moved between $48.28 at its lowest and $90.87 at its peak.

PTCT News

TipRanks 13h
PTC Therapeutics Steps Into Rheumatoid Arthritis With New Phase 2 Study of PTC844

PTC Therapeutics (PTCT) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter, more confid...

Simply Wall St 1d
PTC Therapeutics Shares Moved, What Is Behind The Attention Today?

PTC Therapeutics (PTCT) is in focus after a special call highlighted the expected completion of the ST-920 approval process in Q4 2026, supported by favorable P...

PTC Therapeutics Shares Moved, What Is Behind The Attention Today?
TipRanks 5d
PTC Therapeutics to acquire ST-920 from Sangamo Therapeutics

PTC Therapeutics (PTCT) announced that it was selected as the winning bidder to acquire ST-920 – a BLA-stage one-time administered AAV gene therapy for Fabry di...

Analyst ratings

73%

of 15 ratings
Buy
73.3%
Hold
20%
Sell
6.7%

People also own

Based on the portfolios of people who own PTCT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.